Podcasts about celmatix

Subscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsIn this episode, Dr. Taz discusses the underappreciated significance of ovarian health with Dr. Piraye Beim, a pioneering biologist and women's health advocate. Dr. Beim reveals startling insights into the ovary as a metabolic, immune, and endocrine organ, and she shares how ovarian function is misaligned with modern human lifespans. The conversation also covers Dr. Beim's revolutionary work in ovarian health and longevity. Dr. Beim also shares practical advice on lifestyle changes to optimize ovarian health and addresses the future of reproductive medicine. Join us in understanding why ovarian health deserves more attention and how it can shape the future of women's health.About Dr. Piraye BeimPiraye Yurttas Beim, PhD is the founder and CEO of Celmatix, a preclinical-stage biotech transforming women's lives through better ovarian health.  With its growing pipeline of innovative drug programs including an AMHR2 agonist program focused on ovarian aging and an oral FSH for infertility, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health. Dr. Beim has dedicated herself to innovating in women's health for more than 20 years. During her PhD work at Cornell University (Weill, NYC) and Memorial Sloan Kettering Cancer Center, she was on the front lines of the precision medicine revolution in oncology. She then completed her post-doc at the University of Cambridge (UK), focusing on the science of fertility.Thank you to our sponsorTimeline: timeline.com/DRTAZ06:09 The Role of Ovaries in Human Health12:59 The Impact of Inflammation and Metabolism31:56 Potential Benefits for Women with PCOS37:16 Optimizing Ovarian Health Today40:11 Lifestyle Practices to Support Ovarian Health43:24 The Role of Light and Sleep48:45 Endometriosis and Ovarian Health51:00 Inspiration and Future GoalsStay ConnectedSubscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsFollow Dr. Taz on Instagram: https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Join the conversation on X: https://x.com/@drtazmdTikTok: https://www.tiktok.com/@drtazmdFacebook: https://www.facebook.com/drtazmd/Connect with Dr. Piraye Beim:https://www.instagram.com/boss_ovary/https://bit.ly/m/Boss_OvaryHost & Production TeamHost: Dr. Taz; Produced by Rainbow Creative (Executive Producer: Matthew Jones; Lead Producer: Lauren Feighan; Editors: Jeremiah Schultz and Patrick Edwards)Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+

Dr. Piraye Yurttas Beim, a molecular biologist and entrepreneur, is revolutionizing women's health through her groundbreaking work at Celmatix. With an impressive educational background from the University of Texas at Austin, Cornell University, and the University of Cambridge, Dr. Beim is using her expertise to accelerate precision medicine in women's health. Learn about her journey and the impact she's making in this fascinating interview. Learn more about your ad choices. Visit megaphone.fm/adchoices

Knowledge is power - and that knowledge applies to the ovaries. The more we know about our ovaries, the more prepared we are to ensure they are healthy, plus treat anything that needs attention. Piraye Beim is the Founder & CEO of Celmatix, a preclinical-stage women's health biotech focused uniquely on ovarian biology. Hear how we can use science to improve healthcare, how our ovaries are central command, how we can make sure we have optimally-functioning ovaries, what will happen with the data Celmatix collects, and their go-to-market strategy. Tune in to this episode to support ovarian health!   Learn more: Piraye Beim Celmatix Celmatix LinkedIn   Today's Hot Flash and other stats from: MedicalNewsToday

Mark Adams is the Chief Operating Officer of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Prior to joining Adaptive, Mark served as Managing Director, Healthcare Advanced Analytics, at SVB Leerink, a health and life sciences-focused investment bank, since April 2018. Mark has also served as Chief Information Officer at Celmatix, a women's health precision medicine company, from September 2016 to April 2018, and at Good Start Genetics, a molecular diagnostics company. Mark holds a BA from Oberlin College and a PhD from Baylor College of Medicine. See omnystudio.com/listener for privacy information.

In this episode of Focus on Fertility, Lori Batta, Chief Commericial Officer at Celmatix, joins us to share about the Fertilome test. The Fertilome test is a genetic test that helps to evaluate you DNA make-up for potential fertility risks such as early on-set menopause, ovarian dysfunction, PCOS, recurrent pregnancy loss and much more. Anyone at any point in their fertility journey, whether just starting and giving some considerations on child bearing to those already in an advanced treatment process, can benefit from the information gained through Fertilome. Learn more and how Fertilome can benefit you. Tune in!

In BONUS Episode 145 of Beat Infertility, we interview Angie Lee, chief product officer at Celmatix, about the #SaytheFword campaign. If you need additional support, consider joining Hope University or our Infertility Warrior Tribe. For details on both, please visit https://beatinfertility.co/hopeu.

In BONUS Episode 145 of Beat Infertility, we interview Angie Lee, chief product officer at Celmatix, about the #SaytheFword campaign. Infertility coach Heather Huhman helps warriors like you make scientifically-based, well-informed decisions about your next steps. To schedule your free 30-minute call, go to https://beatinfertility.co/hope.

Every entrepreneur will one day wonder -- can do this? Do I have what it takes? For Piraye Beim, that moment came after Hurricane Sandy flooded her home, uprooted her women's health startup Celmatix before a fundraising round and while she was in the second trimester of her first pregnancy. She'll talk to us about this another survival stories and what any entrepreneur can learn.

Host Dawn Davenport, Executive Director of Creating a Family, the national infertility & adoption education and support nonprofit, interviews Dr. Piraye Beim, founder of Celmatix, a women’s health company using genomics and big data to help women and their doctors make more informed, proactive reproductive health decisions; and Dr. Alan Copperman, managing partner at RMA of NY and Director of the Division of Reproductive Endocrinology and Infertility at Mount Sinai Medical Center. Creating a Family has many free resources related to this topic on our website at www.CreatingaFamily.org. Please leave us a review on iTunes. Thanks. Click to Tweet: http://ctt.ec/gaX1T Share on Facebook: https://www.facebook.com/sharer/sharer.php?u=https%3A//creatingafamily.org/infertility-category/infertility-genetics/ Show Highlights: https://creatingafamily.org/infertility-category/infertility-genetics/   Support the show (https://creatingafamily.org/donation/)

The phrase “game-changing” gets bandied about a lot in entrepreneurial circles. And certainly, in this era of landmark technological change, we are spoilt for choice when it comes to people and products that have changed the way we live. We’re about to introduce you to a woman who raises that bar to life-changing. Someone who is paving the way for millions of women to have more personalized, accurate fertility care. One who has truly moved the medical sciences needle. (Pun intended). Piraye Beim, is indeed a rare woman. A mother to two, soon-to-be three, a world-leading genetic scientist and Founder/CEO at Celmatix – the New York biotech firm putting big data through its paces with some remarkable results. Since launching in 2009, Celmatix has released two world-first products. The first is Polaris, a cloud-based platform that uses big data to optimize the treatment of fertility patients. Its creation was what Beim refers to as a “happy accident” on the way to solving their number one goal –  building the first genetic test for reproductive health. Fertilome, the realization of that mission, was released early this year. Today, Celmatix are well on their way to empowering an entire generation of women to proactively manage their fertility. And Piraye Beim is just getting started. In this week's episode: How critical it is to your success to be a part of a shared community What the business of medicine is like The importance of understanding the story of your customers How Piraye settles the debate between growth and profitability How to find the time to be both a parent and a game-changing entrepreneur & much more! This podcast episode was brought to you by Pipedrive. Made by marketers for marketers and with over 30,000 users worldwide, Pipedrive is one of the best CRM tools in the business. Keep track of all your sales, customers, and leads with their incredibly intuitive dashboard and simple design. Don't try any other CRM tool until you've used Pipedrive first!

Dr. Beim and Jenna discuss the team's mission to empower every woman with the information she needs to make active health decisions as well as the similarities between being an entrepreneur and a scientist.